RecruitingNCT07175285

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Studying Autosomal systemic lupus erythematosus

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Bristol-Myers Squibb
Principal Investigator: Bristol Myers Squibb
Bristol-Myers Squibb
Intervention: Current standard of care treatment options(drug)
Enrollment: 223 enrolled
Eligibility: 16 years · All sexes
Timeline: 2025 – 2032

Study locations (30)

Local Institution - 0062, Mesa, Arizona, United States
Local Institution - 0054, La Jolla, California, United States
Local Institution - 0001, La Palma, California, United States
Rheumatology Center of San Diego, San Diego, California, United States
Local Institution - 0063, Fort Lauderdale, Florida, United States
Local Institution - 0061, Hollywood, Florida, United States
LIFE Clinical Trials, Margate, Florida, United States
Local Institution - 0068, Palm Beach Gardens, Florida, United States
Local Institution - 0069, Atlanta, Georgia, United States
Local Institution - 0065, Willowbrook, Illinois, United States
Local Institution - 0064, Rockville, Maryland, United States
Local Institution - 0034, Ann Arbor, Michigan, United States
AA MRC, Grand Blanc, Michigan, United States
Local Institution - 0070, Kalispell, Montana, United States
Sahni Rheumatology & Therapy, West Long Branch, New Jersey, United States
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07175285 on ClinicalTrials.gov

Other trials for Autosomal systemic lupus erythematosus

Additional recruiting or active studies for the same condition.

See all trials for Autosomal systemic lupus erythematosus →

← Back to all trials